Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial (Englisch)
- Neue Suche nach: Bianchini, G.
- Neue Suche nach: Pusztai, L.
- Neue Suche nach: Pienkowski, T.
- Neue Suche nach: Im, Y. H.
- Neue Suche nach: Bianchi, G. V.
- Neue Suche nach: Tseng, L. M.
- Neue Suche nach: Liu, M. C.
- Neue Suche nach: Lluch, A.
- Neue Suche nach: Galeota, E.
- Neue Suche nach: Magazzù, D.
- Neue Suche nach: Bianchini, G.
- Neue Suche nach: Pusztai, L.
- Neue Suche nach: Pienkowski, T.
- Neue Suche nach: Im, Y. H.
- Neue Suche nach: Bianchi, G. V.
- Neue Suche nach: Tseng, L. M.
- Neue Suche nach: Liu, M. C.
- Neue Suche nach: Lluch, A.
- Neue Suche nach: Galeota, E.
- Neue Suche nach: Magazzù, D.
In:
ANNALS OF ONCOLOGY
;
26
, 12
;
2429-2436
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
-
Beteiligte:Bianchini, G. ( Autor:in ) / Pusztai, L. ( Autor:in ) / Pienkowski, T. ( Autor:in ) / Im, Y. H. ( Autor:in ) / Bianchi, G. V. ( Autor:in ) / Tseng, L. M. ( Autor:in ) / Liu, M. C. ( Autor:in ) / Lluch, A. ( Autor:in ) / Galeota, E. ( Autor:in ) / Magazzù, D. ( Autor:in )
-
Erschienen in:ANNALS OF ONCOLOGY ; 26, 12 ; 2429-2436
-
Verlag:
- Neue Suche nach: OXFORD UNIVERSITY PRESS
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.992
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.992 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 26, Ausgabe 12
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 2361
-
Immunity and HER2-positive disease: never stop questioningLoi, S. et al. | 2015
- 2363
-
Statistical controversies in clinical research: long-term follow-up of clinical trials in cancerCuzick, J. et al. | 2015
- 2367
-
Targeting the undruggable: immunotherapy meets personalized oncology in the genomic eraMartin, S. D. / Coukos, G. / Holt, R. A. / Nelson, B. H. et al. | 2015
- 2375
-
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesNaidoo, J. / Page, D. B. / Li, B. T. / Connell, L. C. / Schindler, K. / Lacouture, M. E. / Postow, M. A. / Wolchok, J. D. et al. | 2015
- 2392
-
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†Kramar, A. / Negrier, S. / Sylvester, R. / Joniau, S. / Mulders, P. / Powles, T. / Bex, A. / Bonnetain, F. / Bossi, A. / Bracarda, S. et al. | 2015
- 2398
-
Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysisIslami, F. / Liu, Y. / Jemal, A. / Zhou, J. / Weiderpass, E. / Colditz, G. / Boffetta, P. / Weiss, M. et al. | 2015
- 2408
-
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studiesLambertini, M. / Ceppi, M. / Poggio, F. / Peccatori, F. A. / Azim, H. A. / Ugolini, D. / Pronzato, P. / Loibl, S. / Moore, H. C. / Partridge, A. H. et al. | 2015
- 2419
-
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureMarous, M. / Bièche, I. / Paoletti, X. / Alt, M. / Razak, A. R. / Stathis, A. / Kamal, M. / Le Tourneau, C. et al. | 2015
- 2429
-
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trialBianchini, G. / Pusztai, L. / Pienkowski, T. / Im, Y. H. / Bianchi, G. V. / Tseng, L. M. / Liu, M. C. / Lluch, A. / Galeota, E. / Magazzù, D. et al. | 2015
- 2437
-
A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRNLeonard, R. C. / Mansi, J. L. / Keerie, C. / Yellowlees, A. / Crawford, S. / Benstead, K. / Matthew, R. / Adamson, D. / Chan, S. / Grieve, R. et al. | 2015
- 2442
-
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialMunzone, E. / Giobbie-Hurder, A. / Gusterson, B. A. / Mallon, E. / Viale, G. / Thürlimann, B. / Ejlertsen, B. / MacGrogan, G. / Bibeau, F. / Lelkaitis, G. et al. | 2015
- 2450
-
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsSunakawa, Y. / Stintzing, S. / Cao, S. / Heinemann, V. / Cremolini, C. / Falcone, A. / Yang, D. / Zhang, W. / Ning, Y. / Stremitzer, S. et al. | 2015
- 2457
-
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinomaKang, Y. K. / Yau, T. / Park, J. W. / Lim, H. Y. / Lee, T. Y. / Obi, S. / Chan, S. L. / Qin, S. / Kim, R. D. / Casey, M. et al. | 2015
- 2464
-
The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancerMiddleton, G. / Crack, L. R. / Popat, S. / Swanton, C. / Hollingsworth, S. J. / Buller, R. / Walker, I. / Carr, T. H. / Wherton, D. / Billingham, L. J. et al. | 2015
- 2470
-
Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancerMichels, J. / Adam, J. / Goubar, A. / Obrist, F. / Damotte, D. / Robin, A. / Alifano, M. / Vitale, I. / Olaussen, K. A. / Girard, P. et al. | 2015
- 2477
-
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancerTakeda, M. / Sakai, K. / Terashima, M. / Kaneda, H. / Hayashi, H. / Tanaka, K. / Okamoto, K. / Takahama, T. / Yoshida, T. / Iwasa, T. et al. | 2015
- 2483
-
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaNowak, A. K. / Cook, A. M. / McDonnell, A. M. / Millward, M. J. / Creaney, J. / Francis, R. J. / Hasani, A. / Segal, A. / Musk, A. W. / Turlach, B. A. et al. | 2015
- 2490
-
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institutionHosing, C. / Bassett, R. / Dabaja, B. / Talpur, R. / Alousi, A. / Ciurea, S. / Popat, U. / Qazilbash, M. / Shpall, E. J. / Oki, Y. et al. | 2015
- 2496
-
Alopecia in patients treated with molecularly targeted anticancer therapiesBelum, V. R. / Marulanda, K. / Ensslin, C. / Gorcey, L. / Parikh, T. / Wu, S. / Busam, K. J. / Gerber, P. A. / Lacouture, M. E. et al. | 2015
- 2503
-
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancerSchirripa, M. / Loupakis, F. / Lonardi, S. / Cremolini, C. / Bergamo, F. / Zagonel, V. / Falcone, A. et al. | 2015
- 2504
-
Comment on ESMO Magnitude of Clinical Benefit ScaleMuhonen, T. / Joensuu, H. / Pfeiffer, P. et al. | 2015
- 2505
-
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancerO'Neil, B. H. / Scott, A. J. / Ma, W. W. / Cohen, S. J. / Leichman, L. / Aisner, D. L. / Menter, A. R. / Tejani, M. A. / Cho, J. K. / Granfortuna, J. et al. | 2015
- 2505
-
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)Gourgou-Bourgade, S. / Cameron, D. / Poortmans, P. / Asselain, B. / Azria, D. / Cardoso, F. / A'Hern, R. / Bliss, J. / Bogaerts, J. / Bonnefoi, H. et al. | 2015
- 2507
-
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsNieto, Y. / Tu, S. M. / Bassett, R. / Jones, R. B. / Gulbis, A. M. / Tannir, N. / Kingham, A. / Ledesma, C. / Margolin, K. / Holmberg, L. et al. | 2015